Patients face medicine shortages as private market buys up drugs
A critical year-long shortage of vital type 2 diabetes medicines is being driven partly by its demand as a weight loss aid, with figures suggesting more than half the prescribing for one drug is through the private market, HSJ has learned.
You need to be a subscriber to read more
Subscribe for unlimited access
With a HSJ subscription you’ll unlock:
- All HSJ news by sector, topic & region
- Breaking News announcements
- App for mobile and offline reading
- Comment and Daily Insights newsletters
- Regional roundup newsletters
- 10 expert briefings every fortnight (Premium only)
- Unrestricted access to ‘Ask HSJ’ - AI assistant - AI assistant (Premium only)
Already a subscriber? Sign into your account here